These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 11390271)

  • 1. Indirect evidence for the potential ability of magnetic resonance imaging to evaluate the myocardial iron content in patients with transfusional iron overload.
    Jensen PD; Jensen FT; Christensen T; Heickendorff L; Jensen LG; Ellegaard J
    MAGMA; 2001 May; 12(2-3):153-66. PubMed ID: 11390271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial iron loading by magnetic resonance imaging T2* in good prognostic myelodysplastic syndrome patients on long-term blood transfusions.
    Chacko J; Pennell DJ; Tanner MA; Hamblin TJ; Wonke B; Levy T; Thomas PW; Killick SB
    Br J Haematol; 2007 Sep; 138(5):587-93. PubMed ID: 17610536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing cardiac and liver iron overload in chronically transfused patients with sickle cell disease.
    Badawy SM; Liem RI; Rigsby CK; Labotka RJ; DeFreitas RA; Thompson AA
    Br J Haematol; 2016 Nov; 175(4):705-713. PubMed ID: 27507431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlative study of iron accumulation in liver, myocardium, and pituitary assessed with MRI in young thalassemic patients.
    Christoforidis A; Haritandi A; Tsitouridis I; Tsatra I; Tsantali H; Karyda S; Dimitriadis AS; Athanassiou-Metaxa M
    J Pediatr Hematol Oncol; 2006 May; 28(5):311-5. PubMed ID: 16772883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac iron overload in transfusion-dependent patients with myelodysplastic syndromes.
    Roy NB; Myerson S; Schuh AH; Bignell P; Patel R; Wainscoat JS; McGowan S; Marchi E; Atoyebi W; Littlewood T; Chacko J; Vyas P; Killick SB
    Br J Haematol; 2011 Aug; 154(4):521-4. PubMed ID: 21689086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between liver iron concentration determined by magnetic resonance imaging and serum ferritin in adolescents with thalassaemia disease.
    Chuansumrit A; Laothamathat J; Sirachainan N; Sungkarat W; Wongwerawattanakoon P; Kumkrua P
    Paediatr Int Child Health; 2016 Aug; 36(3):203-8. PubMed ID: 27595699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of non-invasive assessment in prediction of preclinical cardiac affection in multi-transfused thalassaemia major patients.
    Said Othman KM; Elshazly SA; Heiba NM
    Hematology; 2014 Oct; 19(7):380-7. PubMed ID: 24225039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of transfusional iron overload before and during iron chelation by magnetic resonance imaging of the liver and determination of serum ferritin in adult non-thalassaemic patients.
    Jensen PD; Jensen FT; Christensen T; Ellegaard J
    Br J Haematol; 1995 Apr; 89(4):880-9. PubMed ID: 7772526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Tissue Elastography With Magnetic Resonance Imaging T2* and Serum Ferritin Quantification in Detecting Liver Iron Overload in Patients With Thalassemia Major.
    Pipaliya N; Solanke D; Parikh P; Ingle M; Sharma R; Sharma S; Sawant P
    Clin Gastroenterol Hepatol; 2017 Feb; 15(2):292-298.e1. PubMed ID: 27650324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multislice multiecho T2* cardiovascular magnetic resonance for detection of the heterogeneous distribution of myocardial iron overload.
    Pepe A; Positano V; Santarelli MF; Sorrentino F; Cracolici E; De Marchi D; Maggio A; Midiri M; Landini L; Lombardi M
    J Magn Reson Imaging; 2006 May; 23(5):662-8. PubMed ID: 16568436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deferasirox improves hematologic and hepatic function with effective reduction of serum ferritin and liver iron concentration in transfusional iron overload patients with myelodysplastic syndrome or aplastic anemia.
    Cheong JW; Kim HJ; Lee KH; Yoon SS; Lee JH; Park HS; Kim HY; Shim H; Seong CM; Kim CS; Chung J; Hyun MS; Jo DY; Jung CW; Sohn SK; Yoon HJ; Kim BS; Joo YD; Park CY; Min YH;
    Transfusion; 2014 Jun; 54(6):1542-51. PubMed ID: 24313463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic iron overload in thalassemic patients: proposal and validation of an MRI method of assessment.
    Bonetti MG; Castriota-Scanderbeg A; Criconia GM; Mazza P; Sacco M; Amurri B; Masi C
    Pediatr Radiol; 1996 Sep; 26(9):650-6. PubMed ID: 8781105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of tissue iron overload by nuclear magnetic resonance imaging.
    Johnston DL; Rice L; Vick GW; Hedrick TD; Rokey R
    Am J Med; 1989 Jul; 87(1):40-7. PubMed ID: 2741980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of the ferritin/alanine aspartate transaminase ratio as an iron overload marker independent of liver cell damage.
    Triadou P; Regnat-Lusinchi A; Girot R
    Eur J Haematol; 1989 Nov; 43(5):423-7. PubMed ID: 2612615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of liver iron overload by T2-quantitative magnetic resonance imaging: correlation of T2-QMRI measurements with serum ferritin concentration and histologic grading of siderosis.
    Papakonstantinou OG; Maris TG; Kostaridou V; Gouliamos AD; Koutoulas GK; Kalovidouris AE; Papavassiliou GB; Kordas G; Kattamis C; Vlahos LJ
    Magn Reson Imaging; 1995; 13(7):967-77. PubMed ID: 8583875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Value of magnetic resonance imaging T2* tests in detecting heart and liver iron overload in patients with β-thalassemia major].
    Wu X; Jing Y; Pei F; Chen J; Feng X; He Y; Zhang Y; Li C
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Feb; 33(2):249-52. PubMed ID: 23443782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between myocardial and hepatic T2 and T2* at 1.5T and 3T MRI in normal and iron-overloaded patients.
    Kritsaneepaiboon S; Ina N; Chotsampancharoen T; Roymanee S; Cheewatanakornkul S
    Acta Radiol; 2018 Mar; 59(3):355-362. PubMed ID: 28592152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T2 relaxation time study of iron overload in b-thalassemia.
    Mavrogeni SI; Gotsis ED; Markussis V; Tsekos N; Politis C; Vretou E; Kermastinos D
    MAGMA; 1998 Aug; 6(1):7-12. PubMed ID: 9794284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MRI-Based Liver Iron Content Determination at 3T in Regularly Transfused Patients by Signal Intensity Ratio Using an Alternative Analysis Approach Based on R2* Theory.
    Wunderlich AP; Cario H; Bommer M; Beer M; Schmidt SA; Juchems MS
    Rofo; 2016 Sep; 188(9):846-52. PubMed ID: 27299667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No evidence for myocardial iron overload in multitransfused patients with myelodysplastic syndrome using cardiac magnetic resonance T2 technique.
    Konen E; Ghoti H; Goitein O; Winder A; Kushnir T; Eshet Y; Rachmilewitz E
    Am J Hematol; 2007 Nov; 82(11):1013-6. PubMed ID: 17654681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.